Graham (GHM) has drawn fresh investor focus after entering a Securities Purchase Agreement with T. Rowe Price Investment Management to issue 599,808 common shares at US$83.36 per share, raising about US$50 million.
See our latest analysis for Graham.
The T. Rowe Price investment comes after a strong run in the stock, with a 1 month share price return of 19.33% and a year to date share price return of 43.69%. The 1 year total shareholder return of 232.10% points to momentum that has already been very strong over both shorter and longer horizons.
If Graham’s move has your attention, it can be a good time to see what else is gaining interest in related areas, including 33 power grid technology and infrastructure stocks
With the stock up sharply and trading above a recent analyst price target, the key question now is simple: Is Graham still underappreciated after this T. Rowe Price deal, or is the market already pricing in much stronger growth ahead?
Most Popular Narrative: 5.3% Overvalued
At a last close of $95.38 versus a narrative fair value of $90.60, the current price sits slightly above what this framework supports, so it helps to understand the assumptions behind that gap.
Record backlog growth and strong book to bill ratio signal rising multi year demand, underpinned by sustained U.S. Navy defense programs and increasing global infrastructure investment, supporting future revenue visibility and stability.
Read the complete narrative. Read the complete narrative.
Want to see what justifies paying up for Graham at this level? The narrative leans heavily on expectations for faster compounded revenue growth, higher margins, and a richer future earnings multiple. Curious how those three levers combine to support that fair value estimate and what they imply for profit power several years out? The full story sits inside the detailed assumptions.
Result: Fair Value of $90.60 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, there is still clear downside risk if U.S. defense orders slow, or if newer markets like small modular nuclear and cryogenics take longer to contribute meaningfully.
Find out about the key risks to this Graham narrative.
Next Steps
If this mix of optimism and concern around Graham feels finely balanced, take a moment now to weigh the trade offs yourself by reviewing the 2 key rewards and 1 important warning sign
Looking for more investment ideas?
Do not stop with a single company when there are other clear, data driven ideas ready to review through the Simply Wall St Screener.
- Target reliable cash generators by scanning 12 dividend fortresses, which focus on income potential with elevated yields.
- Zero in on quality at a reasonable price by checking the 60 high quality undervalued stocks, which combine fundamentals with attractive valuations.
- Prioritise peace of mind by reviewing the 71 resilient stocks with low risk scores, designed for resilience across a range of conditions.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com